There are several ongoing clinical trials at KCUMB. To learn more about participating, visit our Volunteer Education Center. If you do not see a study below that interests you, you may still sign up for future studies.
Select a category or scroll down to see all studies now enrolling:
AIDS/HIV
Asthma
Allergies, Seasonal
Cholesterol
Chronic Back Pain
Chronic Bronchitis
COPD
|
Diabetes
Emphysema
Fibromyalgia
Gastro-esophageal Reflux
High Cholesterol
Hypertension/High Blood Pressure
Infectious Disease
|
Influenza
Irritable Bowel Syndrome
Pregnancy
Reactive Airway Disorder
|
Category: Asthma
Title: Protocol D5896C00027: A 26 week, randomized, double-blind, parallel-group, active controlled, multicenter, multinational safety study evaluating the risk of serious asthma-related events during treatment with Symbicort®, a fixed combination of inhaled corticosteroid (ICS) (budesonide) and a long acting β2-agonist (LABA) (formoterol) as compared to treatment with ICS (budesonide) alone in adult and adolescent (≥12 years of age) patients with asthma
Description: We are conducting a medical research study comparing two medications to treat asthma. For more information, visit the study’s pages at clinicaltrials.gov, NCTC01444430
Duration: 26 weeks
Compensation: Investigational medication and study-related care at no cost, as well as compensation for time. Reimbursement for childcare and transportation may be provided.
Eligibility requirements: You may be eligible to participate if you:
- Are between the ages of 18 and 89
- Have been diagnosed with asthma “for at least one year”
- Are taking current “daily” asthma medication
Contact Information: Dybedal Clinical Research Center, crc@kcumb.edu or 1-877-425-0250.